6 results
10/Nov/2023
DOI: 10.31744/einstein_journal/2023RC0319
ABSTRACT A total of 1.67 million breast cancer cases per year are reported worldwide. Of these, 5%–10% are caused by inherited mutations. Phenocopy is a rare phenomenon, with only a few cases reported in the literature. In phenocopies, phenotypes identical to those with genetic origin occur because of environmental factors rather than familial mutations. We describe a case of phenocopy in a 44-year-old female patient with triple-negative breast cancer. The mother and sister wee heterozygous for c.1813delA, p.Ile605TyrfsTer9 in BRCA2 […]
Keywords: Breast neoplasms; Genes BRCA1; Genes BRCA2; Genetic predisposition to disease; Mutation; Phenotype
19/Dec/2022
DOI: 10.31744/einstein_journal/2023AO0100
Highlights Karyotype was normal in 60% of patients and altered in 40%. The variants most often detected in the myeloid panel were: JAK2 (54%), ASXL1 (50%), TET2 (31%), and CALR (22%). The median follow-up of transplant patients was 2.4 years and the two-year overall survival was 80%. ABSTRACT Objective To analyze the karyotype test and myeloid panel with next-generation sequencing findings in patients with myelofibrosis, and to compare transplant characteristics in patients referred for bone marrow transplantation. Methods Retrospective, […]
Keywords: Bone marrow transplantation; Cytogenetic analysis; Mutation; Primary myelofibrosis; Prognosis
13/Oct/2022
DOI: 10.31744/einstein_journal/2022RC0076
ABSTRACT Hereditary hyperferritinemia-cataract syndrome is a rare autosomal dominant disease caused by a genetic mutation in the iron responsive element in the 5’ untranslated region of the ferritin light chain gene. Hereditary hyperferritinemia-cataract syndrome is characterized by elevated serum ferritin levels and bilateral cataract development early in life and may be misdiagnosed as hemochromatosis. This case report describes a Brazilian family with a clinical diagnosis of hereditary hyperferritinemia-cataract syndrome, which was submitted to ferritin light chain gene sequencing. The genetic […]
Keywords: Cataract; Ferritins; Hyperferritinemia; Iron metabolism disorders; Iron overload; Mutation
22/Mar/2022
22/Mar/2022
DOI: 10.31744/einstein_journal/2022AO6450
ABSTRACT Objective To understand the feasibility of FGFR3 tests in the Brazilian public health context, and to sample the mutational burden of this receptor in high-grade muscle invasive bladder cancer. Methods A total of 31 patients with high-grade muscle-invasive bladder cancer were included in the present study. Either transurethral resection of bladder tumor or radical cystectomy specimens were analyzed. Formalin-fixed paraffin-embedded tissue blocks were sectioned, hematoxylin and eosin stained, and histologic sections were reviewed. Total RNA was extracted using the […]
Keywords: Carcinoma, transitional cell; DNA; Mutation; Polymerase chain reaction; Receptor, fibroblast growth factor, type 3; Sequence analysis, DNA; Urinary bladder neoplasms
01/Jul/2017
01/Jul/2017
DOI: 10.1590/S1679-45082017AO4052
ABSTRACT Objective To verify the incidence of the G679A mutation in exon 2 of the gene inhibin alpha (INHA), in women with secondary amenorrhea and diagnosis of premature ovarian insufficiency, and in controls. Methods A 5mL sample of peripheral blood was collected from all study participants in an EDTA tube and was used for DNA extraction. For the patient group, 5mL of blood were also collected in a tube containing heparin for karyotype, and 5mL were collected in a dry […]
Keywords: Inhibins; Menopause, premature; Mutation; Ovarian follicle; Polymorphism, genetic
01/Jul/2010
DOI: 10.1590/S1679-45082010AO1674
ABSTRACT Objective: To evaluate the performance of gene expression analysis in the peripheral blood of Parkinson disease patients with different genetic profiles using microarray as a tool to identify possible diseases related biomarkers which could contribute to the elucidation of the pathological process, as well as be useful in diagnosis. Methods: Global gene expression analysis by means of DNA microarrays was performed in peripheral blood of Parkinson disease patients with previously identified mutations in PARK2 or PARK8 genes, Parkinson disease […]
Keywords: Biological markers/blood; Gene expression; Mutation; Parkinson disease/blood; Parkinson disease/genetics